These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38505144)

  • 41. Histological antiphospholipid-associated nephropathy versus lupus nephritis in patients with systemic lupus erythematosus: an observational cross-sectional study with longitudinal follow-up.
    Gerhardsson J; Sundelin B; Zickert A; Padyukov L; Svenungsson E; Gunnarsson I
    Arthritis Res Ther; 2015 Apr; 17(1):109. PubMed ID: 25927214
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chinese SLE Treatment and Research group (CSTAR) registry: II. Prevalence and risk factors of pulmonary arterial hypertension in Chinese patients with systemic lupus erythematosus.
    Li M; Wang Q; Zhao J; Li Z; Ye Z; Li C; Li X; Zhu P; Wang Z; Zheng Y; Li X; Zhang M; Tian Z; Liu Y; He J; Zhang F; Zhao Y; Zeng X;
    Lupus; 2014 Sep; 23(10):1085-91. PubMed ID: 24651670
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DIAGNOSTIC VALUE OF LABORATORY MARKERS OF SYNTROPIC LESIONS OF THE CIRCULATORY SYSTEM ORGANS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.
    Kobak L; Abrahamovych O; Abrahamovych U; Maksymuk A; Ivanochko R
    Georgian Med News; 2023; (340-341):159-164. PubMed ID: 37805891
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-Nuclear Antibodies Patterns in Patients With Systemic Lupus Erythematosus and Their Correlation With Other Diagnostic Immunological Parameters.
    Al-Mughales JA
    Front Immunol; 2022; 13():850759. PubMed ID: 35359932
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of a high-avidity IgG ANAs for the diagnosis and activity prediction of systemic lupus erythematosus.
    Zeng Y; Lin Y; Wang X; Zhang Y; Peng F; Wang J; Jiang L; Liang S; Xiao Y
    Clin Rheumatol; 2020 Sep; 39(9):2619-2629. PubMed ID: 32189150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
    Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases].
    Quattrocchi P; Barrile A; Bonanno D; Giannetto L; Patafi M; Tigano V; Ferlazzo B
    Reumatismo; 2005; 57(2):109-13. PubMed ID: 15983634
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pulmonary manifestations in systemic lupus erythematosus: pleural involvement, acute pneumonitis, chronic interstitial lung disease and diffuse alveolar hemorrhage.
    Aguilera-Pickens G; Abud-Mendoza C
    Reumatol Clin (Engl Ed); 2018; 14(5):294-300. PubMed ID: 29773465
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systemic Lupus Erythematosus Presenting as Acute Lupus Pneumonitis during Pregnancy.
    Marte Furment M; Sharma S; Pabolu S
    Case Rep Rheumatol; 2020; 2020():8839410. PubMed ID: 33414977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Markers of NETosis in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome.
    Reshetnyak T; Nurbaeva K; Ptashnik I; Kudriaeva A; Belogurov A; Lila A; Nasonov E
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298160
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of respiratory manifestations in systemic lupus erythematosus with special reference to pulmonary interstitial involvement.
    Ghosh A; Das T; Ghosh A; Karmakar P; Pal J
    J Indian Med Assoc; 2012 Feb; 110(2):109-11. PubMed ID: 23029844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determination of the Risk Factors Contributing to the Development of Neuropsychiatric Lupus in a Systemic Lupus Erythematosus Cohort.
    Bankole AA; Kazmi TR; Strazanac AR
    Cureus; 2021 Dec; 13(12):e20129. PubMed ID: 35003967
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Screening characteristics for enrichment of individuals at higher risk for transitioning to classified SLE.
    Young KA; Munroe ME; Guthridge JM; Kamen DL; Gilkensen GS; Harley JB; Weisman MH; Karp DR; Wallace DJ; James JA; Norris JM
    Lupus; 2019 Apr; 28(5):597-606. PubMed ID: 30845880
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Rare Case of Antinuclear Antibody (ANA)-Negative Lupus Nephritis.
    Bakshi N; Munir T; Guma M; Chenitz KB
    Cureus; 2023 Jul; 15(7):e41480. PubMed ID: 37426404
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical features and antinuclear antibodies profile among adults with systemic lupus erythematosus and lupus nephritis: a cross-sectional study.
    Ahmed N; Shigidi M; Al Agib AN; Abdelrahman H; Taha E
    Pan Afr Med J; 2017; 27():114. PubMed ID: 28819535
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-C1q antibodies in systemic lupus erythematosus.
    Orbai AM; Truedsson L; Sturfelt G; Nived O; Fang H; Alarcón GS; Gordon C; Merrill J; Fortin PR; Bruce IN; Isenberg DA; Wallace DJ; Ramsey-Goldman R; Bae SC; Hanly JG; Sanchez-Guerrero J; Clarke AE; Aranow CB; Manzi S; Urowitz MB; Gladman DD; Kalunian KC; Costner MI; Werth VP; Zoma A; Bernatsky S; Ruiz-Irastorza G; Khamashta MA; Jacobsen S; Buyon JP; Maddison P; Dooley MA; Van Vollenhoven RF; Ginzler E; Stoll T; Peschken C; Jorizzo JL; Callen JP; Lim SS; Fessler BJ; Inanc M; Kamen DL; Rahman A; Steinsson K; Franks AG; Sigler L; Hameed S; Pham N; Brey R; Weisman MH; McGwin G; Magder LS; Petri M
    Lupus; 2015 Jan; 24(1):42-9. PubMed ID: 25124676
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dermatological Manifestation of SLE Patients, Living in Aseer Region.
    Alhammadi NA; Alqahtani H; Al Hamdan SA; Al Hamdan JA; Hadhir Alalyani RT; Asiri SAA; Alqahtani RS; Aljari AAM; Asiri GBM
    J Family Med Prim Care; 2024 Apr; 13(4):1249-1253. PubMed ID: 38827701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pediatric systemic lupus erythematosus patients in South Africa have high prevalence and severity of cardiac and vascular manifestations.
    Harrison MJ; Zühlke LJ; Lewandowski LB; Scott C
    Pediatr Rheumatol Online J; 2019 Nov; 17(1):76. PubMed ID: 31771606
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Silica-associated systemic lupus erythematosus with lupus nephritis and lupus pneumonitis: A case report and a systematic review of the literature.
    Fukushima K; Uchida HA; Fuchimoto Y; Mifune T; Watanabe M; Tsuji K; Tanabe K; Kinomura M; Kitamura S; Miyamoto Y; Wada S; Koyanagi T; Sugiyama H; Kishimoto T; Wada J
    Medicine (Baltimore); 2022 Feb; 101(7):e28872. PubMed ID: 35363197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.